Sterile Processing Enters a Partnership-First Phase

Instrumentum’s latest acquisition highlights rising consolidation as US hospitals reassess in-house capacity and costs

16 Jun 2025

Deal activity is picking up in one of healthcare’s least visible but most essential corners: sterile processing.

Instrumentum’s acquisition of Arizona-based Sterile Processing Express, announced in June 2025, is the latest sign that outsourced reprocessing services are moving into a new phase of consolidation. With the deal, Instrumentum expands to five facilities across four states, strengthening its national footprint.

Company leaders frame the move as a step toward meeting rising demand from hospitals and ambulatory surgery centers. Many providers are reassessing whether to keep sterile processing entirely in house or turn to specialized partners.

Sterile Processing Express built its business on offsite cleaning and sterilization of surgical instruments. Folded into Instrumentum’s growing network, the company is expected to boost regional coverage and bring more standardized protocols across sites. Faster turnaround times and consistent quality are key selling points.

Behind the scenes, pressure has been mounting. Health systems continue to grapple with staffing shortages and aging facilities. At the same time, surgical volumes have rebounded in many markets. Procedures are also growing more complex, which means more instruments per case and greater reprocessing demands.

For large service providers, scale is the argument. Operating across multiple facilities allows them to invest in advanced sterilization equipment, digital tracking tools, and compliance systems that might be difficult for a single hospital to finance on its own. Spreading those costs across a broader base can also offer more predictable pricing.

Still, consolidation is not without tradeoffs. Hospitals considering outsourced models must weigh efficiency and expertise against the risks of vendor concentration. Oversight becomes critical as networks expand. Maintaining consistent quality and regulatory compliance across multiple locations is no small task.

The outsourced sterile processing market remains fragmented, leaving room for further acquisitions and partnerships. Analysts expect more strategic moves as companies pursue geographic density and operational efficiency.

What is changing, perhaps most of all, is perception. Sterile processing is no longer seen as a backroom function. It is increasingly viewed as a strategic pillar of surgical performance. As platforms grow and partnerships deepen, reliability and transparency may prove just as important as scale in shaping the sector’s next chapter.